EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NGLY1 as an Emerging Critical Modulator for Neurodevelopment and Pathogenesis in the Brain

Haiwei Zhang iD, Haipeng Xue, Yu-Chieh Wang, Ying Liu iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199705 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Haiwei Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Science, Florida International University, 11350 SW Village Pkwy, Port St. Lucie, FL 34987, USA. Hauptthemen laut MEDLINE: Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase, Brain, Congenital Disorders of Glycosylation, Neurodevelopmental Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, FIU start-up funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N-glycanase 1 (NGLY1) is a cytoplasmic glycoenzyme that removes N-linked glycans from misfolded glycoproteins. It plays an important role in the endoplasmic reticulum-associated degradation (ERAD) pathway in mammalian cells. NGLY1 dysfunction in humans causes NGLY1 deficiency as a rare autosomal recessive disorder that is characterized by neurodevelopmental delay, hypotonia, movement disorders, seizures, and multi-system involvement. In this review, we summarize recent advances in understanding the neural functions of NGLY1 and the neuropathological phenotypes associated with its deficiency. We discuss the molecular basis of NGLY1 deficiency in the central nervous system (CNS) and pathophysiological insights from animal and human induced pluripotent stem cell (iPSC)-based models. We also highlight emerging gene therapy approaches aimed at restoring NGLY1 activity and alleviating neurological symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidaseBrainCongenital Disorders of GlycosylationNeurodevelopmental DisordersHumansAnimalsInduced Pluripotent Stem CellsEndoplasmic Reticulum-Associated Degradation

Stichwörter der Autor:innen

NGLY1 deficiencydisease modelingiPSCsproteostasisrare genetic disorders

Substanzen

Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase

Autor:innen und Institutionen

  • Center for Translational Science, Florida International University, 11350 SW Village Pkwy, Port St. Lucie, FL 34987, USA.
  • Robert Stempel College of Public Health and Social Work, Florida International University, Miami, FL 33199, USA.
  • Applied Biomedical Science Institute, San Diego, CA 92127, USA.
  • OrganoidPro LLC, San Diego, CA 92037, USA.

ORCID-Profile: Haiwei Zhang, Ying Liu

Förderung

  • NINDS NIH HHS
  • NIH HHS
  • FIU start-up funds
  • NIH

Zitieren

APA

Zhang, H., Xue, H., Wang, Y. C., & Liu, Y. (2025). NGLY1 as an Emerging Critical Modulator for Neurodevelopment and Pathogenesis in the Brain. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199705

Vancouver

Zhang H, Xue H, Wang YC, Liu Y. NGLY1 as an Emerging Critical Modulator for Neurodevelopment and Pathogenesis in the Brain. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199705

BibTeX
@article{Zhang2025,
  author = {Zhang, Haiwei and Xue, Haipeng and Wang, Yu-Chieh and Liu, Ying},
  title = {NGLY1 as an Emerging Critical Modulator for Neurodevelopment and Pathogenesis in the Brain},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199705}
}
Kostenlos starten →